Literature DB >> 16460431

Life expectancy in hemophilia outcome.

C Mejia-Carvajal1, E E Czapek, L A Valentino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16460431     DOI： 10.1111/j.1538-7836.2006.01776.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  20 in total

1.  Selecting references that match constructs: the difficult job of citing the parachute hyperbole.

Authors:  Alfonso Iorio; Lorenzo Moja; Alessandro Liberati; Gian Franco Gensini; Roberto Gusinu; Andrea A Conti
Journal:  Intern Emerg Med       Date:  2008-06       Impact factor: 3.397

2.  Perioperative safety and hemostatic efficacy of Advate® in patients with hemophilia A in a postmarketing surveillance in Japan.

Authors:  Keiji Nogami; Hideyuki Takedani; Midori Shima; Akira Yoshioka; Tadashi Matsushita; Junki Takamatsu; Masashi Taki; Katsuyuki Fukutake; Haruhiko Uchikawa; Hiroshi Takagi; Morio Arai; Werner Engl; Akira Shirahata
Journal:  Int J Hematol       Date:  2018-03-28       Impact factor: 2.490

3.  Experimental Validation of ARFI Surveillance of Subcutaneous Hemorrhage (ASSH) Using Calibrated Infusions in a Tissue-Mimicking Model and Dogs.

Authors:  Rebecca E Geist; Chase H DuBois; Timothy C Nichols; Melissa C Caughey; Elizabeth P Merricks; Robin Raymer; Caterina M Gallippi
Journal:  Ultrason Imaging       Date:  2015-11-27       Impact factor: 1.578

Review 4.  Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A.

Authors:  Hans-Christoph Rossbach
Journal:  Vasc Health Risk Manag       Date:  2010-03-03

5.  Retrospective analysis of 1,226 Chinese patients with haemophilia in a single medical centre.

Authors:  Min Xuan; Feng Xue; Rongfeng Fu; Yanhui Yang; Lei Zhang; Mengsu Tian; Renchi Yang
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

Review 6.  Management of Hemophilia in Older Patients.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

Review 7.  Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX.

Authors:  Katherine A Lyseng-Williamson; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 8.  Percutaneous coronary intervention in patients with haemophilia presenting with acute coronary syndrome: an interventional dilemma: case series, review of the literature, and tips for management.

Authors:  Paul Fefer; Sharon Gannot; Aaron Lubetsky; Uri Martinowitz; Shlomi Matetzky; Victor Guetta; Amit Segev
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

9.  Prevalence, incidence, and factor concentrate usage trends of hemophiliacs in Taiwan.

Authors:  Tsu-Chiang Tu; Wen-Shyong Liou; Tsui-Yun Chou; Tsung-Kun Lin; Chuan-Fang Lee; Jye-Daa Chen; Thau-Ming Cham; Mei-Ing Chung
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

Review 10.  The management of hemophilia in elderly patients.

Authors:  Massimo Franchini; Annarita Tagliaferri; Pier Mannuccio Mannucci
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.